Novavax COVID-19 vaccine as a second dose generates high immune response in young people

Published on July 5, 2023

Researchers running the University of Oxford-led Com-COV3 study have reported the results of a study assessing the immune response and side effect profile of ‘mixed’ two-dose COVID-19 vaccine schedules in adolescents aged 12 to 16 years - administering either a full or a one-third (fractional) dose of the Pfizer-BioNTech COVID-19 vaccine or a full dose of the Novavax vaccine at least eight weeks after a first full dose of the Pfizer-BioNTech vaccine.
Continue reading on website
Other news

Aid Agencies at a watershed. Charities need to show they are fit for purpose: Oxford report

July 5, 2023
Underlying assumptions and legitimacy of western INGOs challengedCharities need to show they are fit for purpose – and can adaptSurvival of INGOs is not an end in itselfBut millions need support and the INGOs’ mission is too important for them to be allowed to fail

Poor air quality found to affect mental health in many ways

July 6, 2023
Poor air quality affects mental health in many ways, according to a new review of evidence published in the British Journal of Psychiatry.